[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100621203":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":23,"centralContacts":27,"locations":33,"responsibleParty":48,"collaborators":23,"id":52,"slug":23,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":23,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":23,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":23,"overallStatus":36,"whyStopped":23,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"National Cancer Institute, Egypt","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"CTFB Group","EXPERIMENTAL","Patients will receive an ipsilateral ultrasound-guided costotransverse foramen block with injection of 20 ml bupivacaine 0.25%.",[13],"Other: Costotransverse foramen block",{"label":15,"type":10,"description":16,"interventionNames":17},"ESPB Group","Patients will receive an ipsilateral ultrasound-guided erector spinae plane block with injection of 20 ml bupivacaine 0.25%.",[18],"Other: Erector spinae plane block",[20,24],{"type":6,"name":21,"description":11,"armGroupLabels":22,"otherNames":23},"Costotransverse foramen block",[9],null,{"type":6,"name":25,"description":16,"armGroupLabels":26,"otherNames":23},"Erector spinae plane block",[15],[28],{"name":29,"role":30,"phone":31,"phoneExt":23,"email":32},"Mai M Elrawas, MD","CONTACT","00201222177242","mai.elrawas@nci.cu.edu.eg",[34],{"facility":35,"status":36,"city":37,"state":23,"zip":38,"country":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Cairo University","RECRUITING","Cairo","12613","Egypt",{"type":41,"coordinates":42},"Point",[43,44],31.24967,30.06263,{"lat":44,"lon":43},[47],{"name":29,"role":30,"phone":31,"phoneExt":23,"email":32},{"type":49,"investigatorFullName":50,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":23,"oldOrganization":23},"PRINCIPAL_INVESTIGATOR","Mai Mohamed El Rawas","Assistant professor of Anaesthesia, Intensive Care and Pain Management, National Cancer Institute, Cairo University Cairo University, Cairo, Egypt.","100621203",false,"NCT07367568","Costotransverse Foramen Block With Erector Spinae Plane Block in Modified Radical Mastectomy","Comparison of Costotransverse Foramen Block With Erector Spinae Plane Block in Modified Radical Mastectomy: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Adult females \\> 18 years and ≤ 65 years old.\n* American Society of Anesthesiologists (ASA) physical status П-III.\n* Body mass index (BMI) 18-35 kg\u002Fm2.\n* Scheduled for modified radical mastectomy.\n\nExclusion Criteria:\n\n* Known allergy or hypersensitivity to local anesthetic agents.\n* Active infection at the injection site (e.g., cellulitis, abscess).\n* Coagulopathy or ongoing anticoagulant\u002Fantiplatelet therapy \\[International Normalized Ratio (INR) \\> 1.5 or platelet count \\\u003C 100,000\u002FµL\\].\n* Severe respiratory, cardiac, hepatic, or renal disease.\n* Morbid obesity.\n* Severe cognitive impairment or uncooperative behavior that could interfere with block placement.","FEMALE","18 Years","65 Years",{"count":62,"type":63},110,"ESTIMATED","INTERVENTIONAL",[66],"NA","This study aims to compare the costotransverse foramen block with erector spinae plane block in modified radical mastectomy.",[69,70,71],"Costotransverse Foramen Block","Erector Spinae Plane Block","Modified Radical Mastectomy","2026-01-24",{"date":74,"type":75},"2026-01-27","ACTUAL",{"date":72,"type":75},{"date":78,"type":63},"2026-06-01",{"name":5,"class":6},1]